Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) ...

Kane Biotech, a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, has developed and patented a new bone tissue regenerating ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Scientists have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable ...